• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雷米普利(I)-二硒醚抗癌药物在体外三阴性乳腺癌实验模型中靶向 ROS、TGF-β1、VEGF-A 和 IGF-1。

The rhenium(I)-diselenoether anticancer drug targets ROS, TGF-β1, VEGF-A, and IGF-1 in an in vitro experimental model of triple-negative breast cancers.

机构信息

Society for the Coordination of Therapeutic Researches, 20220, Algajola, France.

Société de Coordination de Recherches Thérapeutiques, 30, avenue du port, 20220, Algajola, France.

出版信息

Invest New Drugs. 2019 Oct;37(5):973-983. doi: 10.1007/s10637-019-00727-1. Epub 2019 Jan 11.

DOI:10.1007/s10637-019-00727-1
PMID:30632005
Abstract

The rhenium(I)-diselenoether complex (Re-diSe) is a rhenium tricarbonyl-based drug chelated by a diselenoether ligand. In this work, we compared its inhibitory effects on the hormone-independent MDA-MB231cancer line and other different cancer cell lines after an exposure time of 72 h by MTT assays. The sensitivity of MDA-MB231 was in the same range than the hormone-dependent MCF-7 breast cancer, the PC-3 prostate and HT-29 colon cancer cells, while the A549 lung and the HeLa uterine cancer cells were less sensitive. We compared the inhibitory effects of Re-diSe and of its diselenide ligand (di-Se) on MDA-MB231 and a normal HEK-293 human embryonic cell line, after 72 h and 120 h of exposure. The cytotoxicity was also studied by flow cytometry using ethidium bromide assays, as well as the effects on the ROS production by DFCA-test, while the levels of TGF-β1, VEGF-A, IGF-1 were addressed by ELISA tests. The dose required to inhibit 50% of the proliferation (IC) of MDA-MB231 breast cancer cells decreased with the time of exposure to 120 h, while the free ligand (di-Se) was found poorly active, demonstrating the important role of Re in this Re-diSe combination. The cytotoxic effects of Re-diSe were highly selective for cancer cells, with a significant increase of the number of dead cancer cells at 5 μM for an exposure time of 120 h, while normal cells were not affected. A remarkable and significant decrease of the production of ROS together with a decrease of VEGF-A, TGF-β1, and IGF-1 by the cancer cells were also observed when cancer cells were exposed to Re-diSe.

摘要

铼(I)-二硒醚配合物(Re-diSe)是一种由二硒醚配体螯合的三羰基铼基药物。在这项工作中,我们通过 MTT 分析比较了其在 72 h 暴露时间后对激素非依赖性 MDA-MB231 癌细胞系和其他不同癌细胞系的抑制作用。MDA-MB231 的敏感性与激素依赖性 MCF-7 乳腺癌、PC-3 前列腺癌和 HT-29 结肠癌细胞相当,而 A549 肺癌和 HeLa 子宫颈癌细胞则不那么敏感。我们比较了 Re-diSe 及其二硒化物配体(di-Se)对 MDA-MB231 和正常 HEK-293 人胚胎细胞系的抑制作用,暴露时间分别为 72 h 和 120 h。还通过溴化乙锭测定法的流式细胞术研究了细胞毒性,通过 DFCA 试验研究了对 ROS 产生的影响,同时通过 ELISA 试验研究了 TGF-β1、VEGF-A 和 IGF-1 的水平。抑制 MDA-MB231 乳腺癌细胞增殖(IC)50 的所需剂量随暴露时间延长至 120 h 而降低,而游离配体(di-Se)的活性较差,表明 Re 在这种 Re-diSe 组合中起重要作用。Re-diSe 的细胞毒性作用对癌细胞具有高度选择性,在 120 h 的暴露时间下,5 μM 时癌细胞死亡数显著增加,而正常细胞不受影响。当癌细胞暴露于 Re-diSe 时,还观察到 ROS 产生显著减少,以及 VEGF-A、TGF-β1 和 IGF-1 减少。

相似文献

1
The rhenium(I)-diselenoether anticancer drug targets ROS, TGF-β1, VEGF-A, and IGF-1 in an in vitro experimental model of triple-negative breast cancers.雷米普利(I)-二硒醚抗癌药物在体外三阴性乳腺癌实验模型中靶向 ROS、TGF-β1、VEGF-A 和 IGF-1。
Invest New Drugs. 2019 Oct;37(5):973-983. doi: 10.1007/s10637-019-00727-1. Epub 2019 Jan 11.
2
Effects of Rhenium(I)-diselenoether and of its Diselenide Ligand on the Production of Cathepsins B and S by MDA-MB231 Breast Malignant Cells.铼(I)-二硒醚及其二硒化物配体对 MDA-MB231 乳腺癌细胞产生组织蛋白酶 B 和 S 的影响。
Anticancer Res. 2021 Dec;41(12):5997-6001. doi: 10.21873/anticanres.15418.
3
Relationship between the oxidative status and the tumor growth in transplanted triple-negative 4T1 breast tumor mice after oral administration of rhenium(I)-diselenoether.口服铼(I)-二硒醚后移植的三阴性 4T1 乳腺癌小鼠氧化状态与肿瘤生长的关系。
J Trace Elem Med Biol. 2022 May;71:126931. doi: 10.1016/j.jtemb.2022.126931. Epub 2022 Jan 17.
4
A New Model Applied for Evaluating a Rhenium-diselenium Drug: Breast Cancer Cells Stimulated by Cytokines Induced from Polynuclear Cells by LPS.一种用于评估雷酸双硒药物的新模型:LPS 诱导多形核细胞产生细胞因子刺激的乳腺癌细胞。
Anticancer Res. 2020 Apr;40(4):1915-1920. doi: 10.21873/anticanres.14146.
5
Effectiveness of Rhenium(I)-diselenoether Low Doses in a Triple-negative Breast Cancer Chicken Embryo Model.铼(I)-二硒醚低剂量在三阴性乳腺癌鸡胚模型中的有效性
Anticancer Res. 2024 Mar;44(3):941-951. doi: 10.21873/anticanres.16889.
6
Molecular biomarkers for prediction of response to treatment and survival in triple negative breast cancer patients from Egypt.埃及三阴性乳腺癌患者治疗反应和生存预测的分子生物标志物
Exp Mol Pathol. 2015 Oct;99(2):303-11. doi: 10.1016/j.yexmp.2015.07.014. Epub 2015 Jul 30.
7
Antitumor activity of a rhenium (I)-diselenoether complex in experimental models of human breast cancer.铼(I)-二硒醚配合物在人乳腺癌实验模型中的抗肿瘤活性
Invest New Drugs. 2015 Aug;33(4):848-60. doi: 10.1007/s10637-015-0265-z. Epub 2015 Jun 26.
8
Dose Effect of Rhenium (I)-diselenoether as Anticancer Drug in Resistant Breast Tumor-bearing Mice After Repeated Administrations.铼(I)-二硒醚作为抗癌药物在多次给药后对荷耐药性乳腺肿瘤小鼠的剂量效应
Anticancer Res. 2016 Nov;36(11):6051-6057. doi: 10.21873/anticanres.11194.
9
Mechanism of metformin action in MCF-7 and MDA-MB-231 human breast cancer cells involves oxidative stress generation, DNA damage, and transforming growth factor β1 induction.二甲双胍对MCF-7和MDA-MB-231人乳腺癌细胞的作用机制涉及氧化应激的产生、DNA损伤以及转化生长因子β1的诱导。
Tumour Biol. 2016 Apr;37(4):5337-46. doi: 10.1007/s13277-015-4395-x. Epub 2015 Nov 11.
10
Transforming growth factor-β, insulin-like growth factor I/insulin-like growth factor I receptor and vascular endothelial growth factor-A: prognostic and predictive markers in triple-negative and non-triple-negative breast cancer.转化生长因子-β、胰岛素样生长因子I/胰岛素样生长因子I受体及血管内皮生长因子-A:三阴性和非三阴性乳腺癌的预后及预测标志物
Mol Med Rep. 2015 Jul;12(1):851-64. doi: 10.3892/mmr.2015.3560. Epub 2015 Mar 27.

引用本文的文献

1
The Effect of Selenium on Endometrial Repair in Goats with Endometritis at High Cortisol Levels.高皮质醇水平子宫内膜炎山羊中硒对子宫内膜修复的影响。
Biol Trace Elem Res. 2024 Jun;202(6):2564-2576. doi: 10.1007/s12011-023-03866-y. Epub 2023 Oct 9.
2
Transition metals in angiogenesis - A narrative review.血管生成中的过渡金属——一篇叙述性综述。
Mater Today Bio. 2023 Aug 3;22:100757. doi: 10.1016/j.mtbio.2023.100757. eCollection 2023 Oct.
3
Evaluation of cytotoxic properties of two fluorescent -Re(CO) complexes bearing an ,-bidentate benzimidazole coligand.

本文引用的文献

1
Reactive Oxygen Species as Regulators of MDSC-Mediated Immune Suppression.活性氧物种作为髓系来源抑制细胞介导免疫抑制的调节因子。
Front Immunol. 2018 Oct 30;9:2499. doi: 10.3389/fimmu.2018.02499. eCollection 2018.
2
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer.阿替利珠单抗联合白蛋白紫杉醇治疗晚期三阴性乳腺癌。
N Engl J Med. 2018 Nov 29;379(22):2108-2121. doi: 10.1056/NEJMoa1809615. Epub 2018 Oct 20.
3
Methylseleninic Acid Sensitizes Ovarian Cancer Cells to T-Cell Mediated Killing by Decreasing PDL1 and VEGF Levels.
对两种带有α,β-双齿苯并咪唑共配体的荧光铼(铼配合物)配合物的细胞毒性特性进行评估。
RSC Adv. 2022 Oct 27;12(47):30829-30837. doi: 10.1039/d2ra05992d. eCollection 2022 Oct 24.
4
Antimicrobial Activity of Rhenium Di- and Tricarbonyl Diimine Complexes: Insights on Membrane-Bound Protein Binding.二羰基和三羰基二亚胺铼配合物的抗菌活性:关于膜结合蛋白结合的见解
Pharmaceuticals (Basel). 2022 Sep 5;15(9):1107. doi: 10.3390/ph15091107.
5
Target-specific mononuclear and binuclear rhenium(i) tricarbonyl complexes as upcoming anticancer drugs.作为新型抗癌药物的靶向单核和双核铼(I)三羰基配合物
RSC Adv. 2022 Jul 14;12(31):20264-20295. doi: 10.1039/d2ra03434d. eCollection 2022 Jul 6.
6
Anticancer and Antibiotic Rhenium Tri- and Dicarbonyl Complexes: Current Research and Future Perspectives.三羰基和二羰基抗癌和抗生素铼配合物:当前研究和未来展望。
Molecules. 2022 Jan 15;27(2):539. doi: 10.3390/molecules27020539.
7
New Amides and Phosphoramidates Containing Selenium: Studies on Their Cytotoxicity and Antioxidant Activities in Breast Cancer.含硒新型酰胺和氨基磷酸酯:乳腺癌细胞毒性及抗氧化活性研究
Antioxidants (Basel). 2021 Apr 11;10(4):590. doi: 10.3390/antiox10040590.
8
Exploring the Potential of Metallodrugs as Chemotherapeutics for Triple Negative Breast Cancer.探索金属药物作为三阴性乳腺癌化疗药物的潜力。
Chemistry. 2021 Jun 21;27(35):8891-8917. doi: 10.1002/chem.202100438. Epub 2021 May 5.
9
Recent Emergence of Rhenium(I) Tricarbonyl Complexes as Photosensitisers for Cancer Therapy.最近出现的铼(I)三羰基配合物作为癌症治疗的光敏剂。
Molecules. 2020 Sep 12;25(18):4176. doi: 10.3390/molecules25184176.
10
The Pro-Oxidant, Apoptotic and Anti-Angiogenic Effects of Selenium Supplementation on Colorectal Tumors Induced by 1,2-Dimethylhydrazine in BALB/C Mice.补充硒对1,2 - 二甲基肼诱导的BALB/C小鼠结直肠癌的促氧化、凋亡及抗血管生成作用
Rep Biochem Mol Biol. 2019 Oct;8(3):216-226.
甲基亚硒酸通过降低PDL1和VEGF水平使卵巢癌细胞对T细胞介导的杀伤敏感。
Front Oncol. 2018 Sep 28;8:407. doi: 10.3389/fonc.2018.00407. eCollection 2018.
4
Immuno-Oncology: Emerging Targets and Combination Therapies.免疫肿瘤学:新兴靶点与联合疗法
Front Oncol. 2018 Aug 23;8:315. doi: 10.3389/fonc.2018.00315. eCollection 2018.
5
Research progress on common adverse events caused by targeted therapy for colorectal cancer.结直肠癌靶向治疗所致常见不良事件的研究进展
Oncol Lett. 2018 Jul;16(1):27-33. doi: 10.3892/ol.2018.8651. Epub 2018 May 7.
6
Anticancer activity of complexes of the third row transition metals, rhenium, osmium, and iridium.第三过渡金属钌、锇、铱配合物的抗癌活性。
Dalton Trans. 2018 Jul 31;47(30):9934-9974. doi: 10.1039/c8dt01858h.
7
nab-Paclitaxel plus carboplatin or gemcitabine versus gemcitabine plus carboplatin as first-line treatment of patients with triple-negative metastatic breast cancer: results from the tnAcity trial.白蛋白结合型紫杉醇联合卡铂或吉西他滨对比吉西他滨联合卡铂作为三阴性转移性乳腺癌一线治疗的患者:tnAcity 试验的结果。
Ann Oncol. 2018 Aug 1;29(8):1763-1770. doi: 10.1093/annonc/mdy201.
8
Managing adverse effects of immunotherapy.免疫疗法不良反应的管理。
Clin Adv Hematol Oncol. 2018 May;16(5):364-374.
9
The Effects of Synthesized Rhenium Acetylsalicylate Compounds on Human Astrocytoma Cell Lines.合成乙酰水杨酸铼化合物对人星形细胞瘤细胞系的影响
J Cancer Sci Ther. 2018;10(2). doi: 10.4172/1948-5956.1000512. Epub 2018 Feb 26.
10
Combined Acylselenourea-Diselenide Structures: New Potent and Selective Antitumoral Agents as Autophagy Activators.酰基硒脲-二硒化物复合结构:作为自噬激活剂的新型高效选择性抗肿瘤药物。
ACS Med Chem Lett. 2018 Mar 13;9(4):306-311. doi: 10.1021/acsmedchemlett.7b00482. eCollection 2018 Apr 12.